Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomic Study of Candesartan in Heart Failure
NCT00400582Phase 4Completed
- Sponsor
- Montréal Heart Institute
- Start
- Nov 2006
- Primary completion
- Apr 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan cilexetil in heart failure (HF), sponsored by Montréal Heart Institute. Started Nov 2006; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00400582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400582.